Fibroma — Trials · CancerIndex

Clinical trials

Registered studies

8 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

clinicaltrialsPublishedShowing 1–4 of 4 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT01526356	Topical Rapamycin to Erase Angiofibromas in TSC(Treatment)	completed	Phase 2	179	The University of Texas Health Science Center, HoustonOTHER	2	Oct 26, 2020	clinicaltrials
NCT02634931	Long-term Trial of Topical Sirolimus to Angiofibroma in Patient With Tuberous Sclerosis Complex	completed	Phase 3	94	NobelpharmaINDUSTRY	1	Feb 20, 2019	clinicaltrials
NCT02635789	Phase III Trial of Topical Formulation of Sirolimus to Skin Lesions in Patients With Tuberous Sclerosis Complex (TSC)	completed	Phase 3	62	NobelpharmaINDUSTRY	1	Feb 2, 2017	clinicaltrials
NCT01031901	Topical Rapamycin Therapy to Alleviate Cutaneous Manifestations of Tuberous Sclerosis Complex (TSC) and Neurofibromatosis I (NF1)

Data updated 22 days agoSource updated Oct 26, 2020source: clinicaltrials